• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用表面增强激光解吸/电离飞行时间质谱法对烟雾病脑脊液中的生物标志物进行研究。

Biomarker research for moyamoya disease in cerebrospinal fluid using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.

作者信息

Maruwaka Mikio, Yoshikawa Kazuhiro, Okamoto Sho, Araki Yoshio, Sumitomo Masaki, Kawamura Akino, Yokoyama Kinya, Wakabayashi Toshihiko

机构信息

Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Division of Advanced Research Promotion Institute of Comprehensive Medical Research, Nagakute-City, Japan; Division of Advanced Medicine Advanced Medical Research Center; Laboratory of Cell Therapy Division of Advanced Medical Research Center.

出版信息

J Stroke Cerebrovasc Dis. 2015 Jan;24(1):104-11. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.028. Epub 2014 Oct 28.

DOI:10.1016/j.jstrokecerebrovasdis.2014.07.028
PMID:25440344
Abstract

Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by steno-occlusive change in bilateral internal carotid arteries with unknown etiology. To discover biomarker candidates in cerebrospinal fluid from MMD patients, proteome analysis was performed by the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. Three peptides, 4473Da, 4475Da, and 6253Da, were significantly elevated in MMD group. A positive correlation between 4473Da peptide and postoperative angiogenesis was determined. Twenty MMD patients were enrolled in this pilot study, including 11 pediatric cases less than 18 years of age (mean age, 8.67 years) and 9 adult MMD patients (mean age, 38.1 years). This study also includes 17 control cases with the mean age of 27.9 years old. In conclusion, 4473Da peptide is supposed to be a reliable biomarker of MMD. 4473Da peptide showed higher intensity peaks especially in younger MMD patients, and it was proved to be highly related to postoperative angiogenesis. Further study is needed to show how 4473Da peptide is involved with the etiology and the onset of MMD.

摘要

烟雾病(MMD)是一种罕见的脑血管疾病,其特征为双侧颈内动脉出现狭窄闭塞性改变,病因不明。为了在烟雾病患者的脑脊液中发现潜在的生物标志物,采用表面增强激光解吸/电离飞行时间质谱法进行了蛋白质组分析。在烟雾病组中,三种肽段(4473Da、4475Da和6253Da)显著升高。确定了4473Da肽段与术后血管生成之间存在正相关。本前瞻性研究纳入了20例烟雾病患者,其中包括11例18岁以下的儿童病例(平均年龄8.67岁)和9例成年烟雾病患者(平均年龄38.1岁)。本研究还包括17例平均年龄为27.9岁的对照病例。总之,4473Da肽段被认为是烟雾病的一种可靠生物标志物。4473Da肽段尤其在年轻烟雾病患者中显示出更高强度的峰,并且已证明其与术后血管生成高度相关。需要进一步研究以揭示4473Da肽段如何参与烟雾病的病因和发病过程。

相似文献

1
Biomarker research for moyamoya disease in cerebrospinal fluid using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.使用表面增强激光解吸/电离飞行时间质谱法对烟雾病脑脊液中的生物标志物进行研究。
J Stroke Cerebrovasc Dis. 2015 Jan;24(1):104-11. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.028. Epub 2014 Oct 28.
2
Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS.采用 SELDI-TOF-MS 技术对脑烟雾病患者脑脊液进行蛋白质组学分析,鉴定新的生物标志物候选物。
BMC Neurol. 2010 Nov 8;10:112. doi: 10.1186/1471-2377-10-112.
3
Elevation of CRABP-I in the cerebrospinal fluid of patients with Moyamoya disease.烟雾病患者脑脊液中CRABP-I水平升高。
Stroke. 2003 Dec;34(12):2835-41. doi: 10.1161/01.STR.0000100159.43123.D7. Epub 2003 Nov 6.
4
Downregulation of Apolipoprotein-E and Apolipoprotein-J in Moyamoya Disease-A Proteome Analysis of Cerebrospinal Fluid.烟雾病中载脂蛋白E和载脂蛋白J的下调——脑脊液的蛋白质组分析
J Stroke Cerebrovasc Dis. 2017 Dec;26(12):2981-2987. doi: 10.1016/j.jstrokecerebrovasdis.2017.07.028. Epub 2017 Aug 23.
5
Elevation of Proenkephalin 143-183 in Cerebrospinal Fluid in Moyamoya Disease.烟雾病患者脑脊液中前脑啡肽143 - 183水平升高。
World Neurosurg. 2018 Jan;109:e446-e459. doi: 10.1016/j.wneu.2017.09.204. Epub 2017 Oct 13.
6
Comparison of peptide nucleic acid fluorescence in situ hybridization assays with culture-based matrix-assisted laser desorption/ionization-time of flight mass spectrometry for the identification of bacteria and yeasts from blood cultures and cerebrospinal fluid cultures.比较基于肽核酸荧光原位杂交技术和基于培养物的基质辅助激光解吸/电离飞行时间质谱法鉴定血培养和脑脊液培养中的细菌和酵母菌。
Clin Microbiol Infect. 2014 Aug;20(8):O468-75. doi: 10.1111/1469-0691.12490. Epub 2014 Jan 13.
7
Saliva analysis by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF-MS) in orthodontic treatment: first pilot study.表面增强激光解吸/电离飞行时间质谱法(SELDI-TOF-MS)在正畸治疗中的唾液分析:初步研究。
Prog Orthod. 2011 Nov;12(2):126-31. doi: 10.1016/j.pio.2011.06.002. Epub 2011 Jul 26.
8
MSQ: a tool for quantification of proteomics data generated by a liquid chromatography/matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry based targeted quantitative proteomics platform.MSQ:一种用于量化基于液相色谱/基质辅助激光解吸/电离飞行时间串联质谱的靶向定量蛋白质组学平台产生的蛋白质组学数据的工具。
Rapid Commun Mass Spectrom. 2010 Feb;24(4):403-8. doi: 10.1002/rcm.4407.
9
Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.使用液相色谱基质辅助激光解吸/电离飞行时间串联质谱仪(LC MALDI TOF/TOF)平台进行靶向定量蛋白质组学分析在人脑脊液中的应用。
J Proteome Res. 2008 Feb;7(2):720-30. doi: 10.1021/pr700630x. Epub 2008 Jan 11.
10
[Screening of potential proteins from patients with idiopathic pulmonary fibrosis by using of surface enhanced laser desorption/ionization time of flight mass spectrum].[利用表面增强激光解吸/电离飞行时间质谱筛选特发性肺纤维化患者潜在蛋白质]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012 Jul;24(7):427-30.

引用本文的文献

1
Advances in moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions.烟雾病的进展:发病机制、诊断及治疗干预
MedComm (2020). 2025 Jan 14;6(2):e70054. doi: 10.1002/mco2.70054. eCollection 2025 Feb.
2
Increase of Circulating Endothelial Progenitor Cells and Released Angiogenic Factors in Children with Moyamoya Arteriopathy.儿童烟雾病患者循环内皮祖细胞和释放的血管生成因子增加。
Int J Mol Sci. 2023 Jan 8;24(2):1233. doi: 10.3390/ijms24021233.
3
The preoperative focal cerebral blood flow status may be associated with slow flow in the bypass graft after combined surgery for moyamoya disease.
烟雾病联合手术后,术前局部脑血流状态可能与搭桥血管血流缓慢有关。
Surg Neurol Int. 2022 Nov 4;13:511. doi: 10.25259/SNI_772_2022. eCollection 2022.
4
Changes in cerebral blood flow in the postoperative chronic phase after combined cerebral revascularization for moyamoya disease with ischaemic onset.烟雾病缺血性发作患者联合脑血运重建术后慢性期脑血流变化。
Neurosurg Rev. 2022 Jun;45(3):2471-2480. doi: 10.1007/s10143-022-01774-8. Epub 2022 Mar 23.
5
Genetic and Proteomic Contributions to the Pathophysiology of Moyamoya Angiopathy and Related Vascular Diseases.遗传和蛋白质组学对烟雾病血管病变及相关血管疾病病理生理学的贡献。
Appl Clin Genet. 2021 Mar 18;14:145-171. doi: 10.2147/TACG.S252736. eCollection 2021.
6
Metabolomic Profiling Revealed Potential Biomarkers in Patients With Moyamoya Disease.代谢组学分析揭示了烟雾病患者潜在的生物标志物。
Front Neurosci. 2020 Apr 21;14:308. doi: 10.3389/fnins.2020.00308. eCollection 2020.
7
A new horizon of moyamoya disease and associated health risks explored through RNF213.通过RNF213探索烟雾病的新视野及相关健康风险。
Environ Health Prev Med. 2016 Mar;21(2):55-70. doi: 10.1007/s12199-015-0498-7. Epub 2015 Dec 10.
8
Moyamoya Biomarkers.烟雾病生物标志物
J Korean Neurosurg Soc. 2015 Jun;57(6):415-21. doi: 10.3340/jkns.2015.57.6.415. Epub 2015 Jun 30.